Philippe Matthews Show Guru Advice, Author Reviews, Tech Reviews, Entertainment News

This past week, I was jolted out of my chair by news that a Pfizer-led group plans to buy access to patient data in hospitals . My initial reaction was anger, on a variety of levels: as a researcher, as one who is increasingly wary of the reach of huge corporations, and as an individual

Almost every other industry has figured out a way to give back while still making a profit. But health-care providers, insurance companies, and big pharma still are trying to squeeze every last dollar out of patients, with bad results.

By taking lists of potential side effects out of the hands of the drug makers, the startup is letting people know what their pills might be doing to them in a more open way than big pharmaceutical companies ever have. Last week during a Republican debate, as you may have heard, Michele Bachmann claimed that the HPV vaccine Gardasil can cause mental retardation. Prozac and other antidepressants are often linked to suicide .

A new therapy that has caught my attention is hyperbaric oxygen therapy (HOT). When I read the different illnesses it cures, it seems too good to be true. Entrepreneurs are always looking for the next big thing

As CEO of Novartis, Europe's second largest drug company, the former competitive swimmer Joe Jimenez won't rest until he snags the top spot. The key: innovative products, expansion into new markets, and good old-fashioned team building. As a teenager, Joe Jimenez spent four hours a day, seven days a week in the pool training for swim meets

As we process applications for this year's Inc.

By Marian Turner of Nature magazine Man's best friend bears a heavy burden in the pharmaceutical industry. [More]

Medicis Pharmaceutical Corp's newer anti-wrinkle drug Dysport proved significantly better than Botox at improving crow's feet in a small clinical study, a finding that could give frown lines to market leader Allergan Inc.

Sen. Baucus seeks to force doctors and medical associations who lobby the FDA to disclose their pharmaceutical company ties